Gut Microbiota: Mining for Therapeutic Potential

Slides:



Advertisements
Similar presentations
The Cytosolic Bacterial Peptidoglycan Sensor Nod2 Affords Stem Cell Protection and Links Microbes to Gut Epithelial Regeneration 王鐘漢.
Advertisements

Immunity in the Gut Andrew M. Platt, University of Glasgow, UK
Innate immunity in the large intestine
Herbert Tilg, Timon E. Adolph  Cell Metabolism 
Alan N. Desmond, Sebastian McWilliams, Michael M
Microbial Influences in Inflammatory Bowel Diseases
Pichamol Jirapinyo, Christopher C. Thompson 
Covering the Cover Gastroenterology
Volume 139, Issue 5, Pages (November 2010)
Celiac Disease and Persistent Symptoms
Microbial Symbiosis with the Innate Immune Defense System of the Skin
Tumor necrosis factor: Biology and therapeutic inhibitors
Immunosensory detection of intestinal bacteria.
David L. McCollum, J. Martin Rodriguez 
The Gastrointestinal Tract and AIDS Pathogenesis
IL-33 Raises Alarm Immunity Volume 31, Issue 1, Pages 5-7 (July 2009)
Benoit Chassaing, Arlette Darfeuille–Michaud  Gastroenterology 
R. Balfour Sartor, MD  Clinical Gastroenterology and Hepatology 
Volume 151, Issue 4, Pages (October 2016)
Probiotics in Transition
Volume 134, Issue 5, Pages (May 2008)
Kaoru Geddes, Dana J. Philpott  Gastroenterology 
Dieter Demon, Lieselotte Vande Walle, Mohamed Lamkanfi 
Eamonn M.M. Quigley  Clinical Gastroenterology and Hepatology 
Intestinal Permeability Defects: Is It Time to Treat?
ER stress-induced inflammation: does it aid or impede disease progression?  Abhishek D. Garg, Agnieszka Kaczmarek, Olga Krysko, Peter Vandenabeele, Dmitri.
Warren Strober, Ivan J. Fuss  Gastroenterology 
Carbohydrate Maldigestion and Malabsorption
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Probiotics in Perspective
Nod2 in Normal and Abnormal Intestinal Immune Function
Advances and Perspectives in the Genetics of Inflammatory Bowel Diseases  Mathias Chamaillard, Razvan Iacob, Pierre Desreumaux, Jean–Frederic Colombel 
Kara Gross Margolis, Charalabos Pothoulakis  Gastroenterology 
Bridging immunity and lipid metabolism by gut microbiota
The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System  Yuuki Obata, Vassilis Pachnis  Gastroenterology 
Percy A. Knolle, Robert Thimme  Gastroenterology 
Chengcheng Jin, Jorge Henao-Mejia, Richard A. Flavell  Cell Metabolism 
Mechanisms of Disease: Inflammatory Bowel Diseases
Innate sensors of pathogen and stress: Linking inflammation to obesity
Vaccinating Against Helicobacter pylori: Dissecting the Mechanism
Mechanisms Underlying Inflammation in Neurodegeneration
Regulation of intestinal epithelial gene expression in hypoxia
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Translating Inflammatory Bowel Disease Research into Clinical Medicine
The Role of TIM-4 in Food Allergy
Inflammasomes in Intestinal Inflammation and Cancer
Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange  Sandra Y. Wotzka, Bidong D. Nguyen,
The Fire Within: Microbes Inflame Tumors
Drivers of chronic rhinosinusitis: Inflammation versus infection
Volume 139, Issue 4, Pages (October 2010)
Homeostasis and Inflammation in the Intestine
The Gastrointestinal Tumor Microenvironment
Issue Highlights Clinical Gastroenterology and Hepatology
Interleukin-18 in Intestinal Inflammation: Friend and Foe?
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
Inflammasome Complexes: Emerging Mechanisms and Effector Functions
Bacterial Overgrowth in Intestinal Lipomatosis With Pandiverticulosis
Christoph Becker, Alastair J. Watson, Markus F. Neurath 
Route Connection: Mouth to Intestine in Colitis
NOD1 and NOD2: Signaling, Host Defense, and Inflammatory Disease
Coagulation in Liver Disease: A Guide for the Clinician
Learning Tolerance while Fighting Ignorance
Coloduodenal Fistula in Crohn’s Disease
NOD2 and Crohn’s Disease: Loss or Gain of Function?
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Medical Therapy for Refractory Pediatric Crohn’s Disease
Epithelial mechanisms of vitamin D: (1) increased VDR activity is shown to repress NF-κB-dependent epithelial apoptosis pathways in experimental colitis.
Clara Abraham, Ruslan Medzhitov  Gastroenterology 
The Tuning of the Gut Nervous System by Commensal Microbiota
Presentation transcript:

Gut Microbiota: Mining for Therapeutic Potential Ann M. O’Hara, Fergus Shanahan  Clinical Gastroenterology and Hepatology  Volume 5, Issue 3, Pages 274-284 (March 2007) DOI: 10.1016/j.cgh.2006.12.009 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Changes in intestinal structure and function in germ-free animals compared with colonized animals raised under conventional conditions. Reconstitution of germ-free mice with a microbiota restores the mucosal immune system, and commensal bacteria exert numerous protective, structural, and metabolic effects on the intestinal epithelium. Clinical Gastroenterology and Hepatology 2007 5, 274-284DOI: (10.1016/j.cgh.2006.12.009) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Possible mechanisms contributing to the association of mutations in the CARD15 gene with Crohn’s disease. CARD15 encodes the NOD protein, NOD2, which is expressed in the cytosol of cells of the macrophage/monocyte lineage, DCs, and enterocytes. Stimulation of NOD2 by MDP of bacterial peptidoglycan leads to the activation of the transcription factor NF-κB, and peptidoglycan can signal also to antigen-presenting cells through TLR2. (A) In normal mucosa, TLR2-driven activation of NF-κB is negatively regulated by non-mutated NOD2, thereby preventing excessive production of the proinflammatory Th1 cytokines IL-12 and IFN-γ. Conversely, in NOD2-deficient cells, IL-10 secretion is decreased, and Th1-cell–mediated inflammation occurs through IL-12 as a result of NOD2 to negatively regulate TLR2 signaling. (B) Alternatively, it has been postulated that in antigen-presenting cells expressing mutated NOD2, MDP elevates NF-κB activation and results in excessive IL-1β production and uncontrolled apoptosis, which together might mediate the pathogenesis of Crohn’s disease. (C) Deficient expression of NOD2 by intestinal enterocytes, particularly by Paneth’s cells at the base of the small intestinal crypts, results in decreased secretion of antimicrobial peptides known as α-defensins. Impaired NOD-2–dependent α-defensin production might lead to increased bacterial colonization and a type of bacterial overgrowth that triggers an immunologic response to the microbiota. Clinical Gastroenterology and Hepatology 2007 5, 274-284DOI: (10.1016/j.cgh.2006.12.009) Copyright © 2007 AGA Institute Terms and Conditions